Canada markets closed

Sutro Biopharma, Inc. (S09.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.4200+0.4200 (+14.00%)
At close: 03:29PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
169,359
153,731
67,772
61,880
42,722
Operating Expenses
Research Development
218,332
180,425
137,171
104,400
76,961
Selling General and Administrative
57,165
62,584
59,544
56,004
36,818
Total Operating Expenses
275,497
243,009
196,715
160,404
113,779
Operating Income or Loss
-106,138
-89,278
-128,943
-98,524
-71,057
Interest Expense
35,848
23,750
3,346
3,137
3,974
Total Other Income/Expenses Net
17,075
9,917
12,130
-4,454
41,498
Income Before Tax
-106,796
-88,601
-116,704
-105,538
-32,025
Income Tax Expense
17,654
18,192
2,500
0
103
Income from Continuing Operations
-124,450
-106,793
-119,204
-105,538
-32,128
Net Income
-124,450
-106,793
-119,204
-105,538
-32,128
Net Income available to common shareholders
-124,450
-106,793
-119,204
-105,538
-32,128
Basic EPS
-2.91
-1.78
-2.35
-2.29
-0.99
Diluted EPS
-2.91
-1.78
-2.35
-2.29
-0.99
Basic Average Shares
59,193
60,164
50,739
46,119
32,573
Diluted Average Shares
59,193
60,164
50,739
46,119
32,573